Published in Gene Therapy Weekly, April 3rd, 1995
The findings suggest that a combination of genetic tests and brain scans with a positron emission tomography (PET) scanner may help identify patients in the very early stages of the disease.
Since gene research in Alzheimer's is still young, the findings won't have an immediate impact on diagnosis, said the lead researcher, Dr. Gary Small of the University of California, Los Angeles (UCLA), School of Medicine.
But it may help scientists who...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1995-04-03)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.